13F Pro

SEC Form 4 reporting owner

Stengone Carmine N.

Stengone Carmine N. has filed 11 Form 4 transactions reported between January 30, 2026 and September 8, 2026, as CEO and President of Contineum Therapeutics, Inc. and Director of KIORA PHARMACEUTICALS INC.

Name as filed: Stengone Carmine N.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$160K
1 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 8, 2026
transaction date

Roles and reported holdings

  • CTNMContineum Therapeutics, Inc.
    Jan 30, 2026 – Sep 8, 2026

    CEO and President

    Held directly17,217 sh as of Jun 30, 2026 · Form 4

    24 months: $160K sold

  • KPRXKIORA PHARMACEUTICALS INC
    Jun 10, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 11 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 8, 2026CTNMCEO and PresidentOption exerciseCode M · direct2,500$3K@ $1.01Form 4
Aug 3, 2026CTNMCEO and PresidentOption exerciseCode M · direct2,500$3K@ $1.01Form 4
Jul 8, 2026CTNMCEO and PresidentOption exerciseCode M · direct2,500$3K@ $1.01Form 4
Jun 30, 2026CTNMCEO and PresidentOpen-market saleCode S · direct10,000$160K@ $16.01Form 4
Jun 30, 2026CTNMCEO and PresidentOption exerciseCode M · direct2,500$3K@ $1.26Form 4
Jun 30, 2026CTNMCEO and PresidentOption exerciseCode M · direct7,500$8K@ $1.01Form 4
Jun 10, 2026KPRXDirectorGrant or awardCode A · direct25,000—Form 4
Feb 25, 2026CTNMCEO and PresidentOption exerciseCode M · direct2,700$3K@ $1.26Form 4
Feb 24, 2026CTNMCEO and PresidentOption exerciseCode M · direct4,400$6K@ $1.26Form 4
Feb 11, 2026CTNMCEO and PresidentOption exerciseCode M · direct400$504@ $1.26Form 4
Jan 30, 2026CTNMCEO and PresidentGrant or awardCode A · direct445,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.